Interplay between mutational and horizontally acquired resistance mechanisms and its association with carbapenem resistance amongst extensively drug-resistant Pseudomonas aeruginosa (XDR-PA)

International Journal of Antimicrobial Agents

Volumn 39, Issue 3, 2012, Pages 217-222

  Shu, Jwu Ching ^a   Chia, Ju Hsin ^a,b   Siu, Leung Kei ^c   Kuo, An Jing ^a,b   Huang, Shu Huan ^b   Su, Lin Hui ^a,b   Wu, Tsu Lan ^a,b  

^a CHANG GUNG UNIVERSITY   (Taiwan)

^b CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^c NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

Author keywords

Carbapenem resistance; Efflux pump; Extensively drug resistant Pseudomonas aeruginosa (XDR PA); Metallo lactamase; MIC; Porin

Indexed keywords

AMIKACIN; AZTREONAM; CARBAPENEM; CEFEPIME; CEFTAZIDIME; CIPROFLOXACIN; DORIPENEM; GENTAMICIN; IMIPENEM; MEROPENEM; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIAL MUTATION; BACTERIUM ISOLATION; BLA GENE; CONTROLLED STUDY; GENE EXPRESSION; GENE OVEREXPRESSION; GENOTYPE; HORIZONTAL GENE TRANSFER; METALLO BETA LACTAMASE GENE; MEXA GENE; MEXAB GENE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; NUCLEOTIDE SEQUENCE; OPRD GENE; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; PULSED FIELD GEL ELECTROPHORESIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TAIWAN;

BACTERIAL OUTER MEMBRANE PROTEINS; BETA-LACTAMASES; CARBAPENEMS; DISEASE TRANSMISSION, INFECTIOUS; DRUG RESISTANCE, BACTERIAL; ELECTROPHORESIS, GEL, PULSED-FIELD; GENE EXPRESSION REGULATION, BACTERIAL; GENE TRANSFER, HORIZONTAL; GENES, BACTERIAL; GENOTYPE; MEMBRANE TRANSPORT PROTEINS; MICROBIAL SENSITIVITY TESTS; MUTATION; PORINS; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 84857058336     PISSN: 09248579     EISSN: 18727913     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2011.09.023     Document Type: Article

References (33)

1. B.P. O'Sullivan, and S.D. Freedman Cystic fibrosis Lancet 373 2009 1891 1904
2. M.E. Falagas, and D.E. Karageorgopoulos Pandrug resistance (PDR), extensive drug resistance (XDR), and multidrug resistance (MDR) among Gram-negative bacilli: need for international harmonization in terminology Clin Infect Dis 46 2008 1121 1122 (Pubitemid 351589881)
3. P.D. Lister, D.J. Wolter, and N.D. Hanson Antibacterial-resistant Pseudomonas aeruginosa: clinical impact and complex regulation of chromosomally encoded resistance mechanisms Clin Microbiol Rev 22 2009 582 610
4. T.R. Fritsche, H.S. Sader, M.A. Toleman, T.R. Walsh, and R.N. Jones Emerging metallo-β-lactamase-mediated resistances: a summary report from the worldwide SENTRY Antimicrobial Surveillance Program Clin Infect Dis 41 Suppl. 4 2005 S276 S278
5. J.M. Rodríguez-Martínez, L. Poirel, and P. Nordmann Extended-spectrum cephalosporinases in Pseudomonas aeruginosa Antimicrob Agents Chemother 53 2009 1766 1771
6. J.M. Rodríguez-Martínez, L. Poirel, and P. Nordmann Molecular epidemiology and mechanisms of carbapenem resistance in Pseudomonas aeruginosa Antimicrob Agents Chemother 53 2009 4783 4788
7. J. Trias, and H. Nikaido Outer membrane protein D2 catalyzes facilitated diffusion of carbapenems and penems through the outer membrane of Pseudomonas aeruginosa Antimicrob Agents Chemother 34 1990 52 57 (Pubitemid 20019963)
8. D.M. Livermore Interplay of impermeability and chromosomal β-lactamase activity in imipenem-resistant Pseudomonas aeruginosa Antimicrob Agents Chemother 36 1992 2046 2048
9. J. Quale, S. Bratu, J. Gupta, and D. Landman Interplay of efflux system, ampC, and oprD expression in carbapenem resistance of Pseudomonas aeruginosa clinical isolates Antimicrob Agents Chemother 50 2006 1633 1641
10. Clinical and Laboratory Standards Institute Performance standards for antimicrobial susceptibility testing; twentieth informational supplement. Document M100-S20 2010 CLSI Wayne, PA
11. L.H. Su, H.S. Leu, Y.P. Chiu, J.H. Chia, A.J. Kuo, and C.F. Sun Molecular investigation of two clusters of hospital-acquired bacteraemia caused by multi-resistant Klebsiella pneumoniae using pulsed-field gel electrophoresis and in frequent restriction site PCR. Infection Control Group J Hosp Infect 46 2000 110 117
12. F.C. Tenover, R.D. Arbeit, R.V. Goering, P.A. Mickelsen, B.E. Murray, and D.H. Persing Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing J Clin Microbiol 33 1995 2233 2239
13. S. Lee, Y.J. Park, M. Kim, H.K. Lee, K. Han, and C.S. Kang Prevalence of Ambler class A and D β-lactamases among clinical isolates of Pseudomonas aeruginosa in Korea J Antimicrob Chemother 56 2005 122 127 (Pubitemid 41418345)
14. H. Vahaboglu, R. Ozturk, H. Akbal, S. Saribas, O. Tansel, and F. Coskunkan Practical approach for detection and identification of OXA-10-derived ceftazidime-hydrolyzing extended-spectrum β-lactamases J Clin Microbiol 36 1998 827 829 (Pubitemid 28093278)
15. J.J. Yan, P.R. Hsueh, W.C. Ko, K.T. Luh, S.H. Tsai, and H.M. Wu Metallo-β-lactamases in clinical Pseudomonas isolates in Taiwan and identification of VIM-3, a novel variant of the VIM-2 enzyme Antimicrob Agents Chemother 45 2001 2224 2228
16. C. Llanes, D. Hocquet, C. Vogne, D. Benali-Baitich, C. Neuwirth, and P. Plesiat Clinical strains of Pseudomonas aeruginosa overproducing MexAB-OprM and MexXY efflux pumps simultaneously Antimicrob Agents Chemother 48 2004 1797 1802 (Pubitemid 38544391)
17. M.W. Pfaffl A new mathematical model for relative quantification in real-time RT-PCR Nucleic Acids Res 29 2001 e45
18. G. Cabot, A.A. Ocampo-Sosa, F. Tubau, M.D. Macia, C. Rodríguez, and B. Moya Overexpression of AmpC and efflux pumps in Pseudomonas aeruginosa isolates from bloodstream infections: prevalence and impact on resistance in a Spanish multicenter study Antimicrob Agents Chemother 55 2011 1906 1911
19. A. Farra, S. Islam, A. Stralfors, M. Sorberg, and B. Wretlind Role of outer membrane protein OprD and penicillin-binding proteins in resistance of Pseudomonas aeruginosa to imipenem and meropenem Int J Antimicrob Agents 31 2008 427 433
20. C.H. Leung, N.Y. Wang, C.P. Liu, L.C. Weng, F.C. Hsieh, and C.M. Lee Antimicrobial therapy and control of multidrug-resistant Pseudomonas aeruginosa bacteremia in a teaching hospital in Taiwan J Microbiol Immunol Infect 41 2008 491 498
21. N. Tsuchimochi, T. Takuma, N. Shimono, Y. Nagasaki, Y. Uchida, and M. Harada Antimicrobial susceptibility and molecular epidemiological analysis of clinical strains of Pseudomonas aeruginosa J Infect Chemother 14 2008 99 104 (Pubitemid 351624456)
22. S. Jayakumar, and B. Appalaraju Prevalence of multi and pan drug resistant Pseudomonas aeruginosa with respect to ESBL and MBL in a tertiary care hospital Indian J Pathol Microbiol 50 2007 922 925 (Pubitemid 350305541)
23. F. Shahcheraghi, F. Badmasti, and M.M. Feizabadi Molecular characterization of class 1 integrons in MDR Pseudomonas aeruginosa isolated from clinical settings in Iran, Tehran FEMS Immunol Med Microbiol 58 2010 421 425
24. M. Souli, I. Galani, and H. Giamarellou Emergence of extensively drug-resistant and pandrug-resistant Gram-negative bacilli in Europe Euro Surveill 13 2008 pii:19045
25. A.J. Kallen, A.I. Hidron, J. Patel, and A. Srinivasan Multidrug resistance among Gram-negative pathogens that caused healthcare-associated infections reported to the National Healthcare Safety Network, 2006-2008 Infect Control Hosp Epidemiol 31 2010 528 531
26. S.P. Tseng, J.C. Tsai, L.J. Teng, and P.R. Hsueh Dissemination of transposon Tn6001 in carbapenem-non-susceptible and extensively drug-resistant Pseudomonas aeruginosa in Taiwan J Antimicrob Chemother 64 2009 1170 1174
27. L. Vettoretti, N. Floret, D. Hocquet, B. Dehecq, P. Plesiat, and D. Talon Emergence of extensive-drug-resistant Pseudomonas aeruginosa in a French university hospital Eur J Clin Microbiol Infect Dis 28 2009 1217 1222
28. V.H. Tam, K.T. Chang, K. Abdelraouf, C.G. Brioso, M. Ameka, and L.A. McCaskey Prevalence, resistance mechanisms, and susceptibility of multidrug-resistant bloodstream isolates of Pseudomonas aeruginosa Antimicrob Agents Chemother 54 2010 1160 1164
29. E. Riera, G. Cabot, X. Mulet, M. García-Castillo, R. del Campo, and C. Juan Pseudomonas aeruginosa carbapenem resistance mechanisms in Spain: impact on the activity of imipenem, meropenem and doripenem J Antimicrob Chemother 66 2011 2022 2027
30. M. Tomás, M. Doumith, M. Warner, J.F. Turton, A. Beceiro, and G. Bou Efflux pumps, OprD porin, AmpC β-lactamase, and multiresistance in Pseudomonas aeruginosa isolates from cystic fibrosis patients Antimicrob Agents Chemother 54 2010 2219 2224
31. VIM-2 in clinical isolates of Pseudomonas aeruginosa J Med Microbiol 58 2009 1080 1085
32. E.S. Sohn, J.S. Yoo, J.K. Lee, K.M. Lee, G.T. Chung, and E.S. Shin Investigation of β-lactamase-producing multidrug-resistant Pseudomonas aeruginosa isolated from non-tertiary care hospitals in Korea J Microbiol Biotechnol 17 2007 1733 1737 (Pubitemid 350090358)
33. J.H. Chia, L.H. Su, M.H. Lee, A.J. Kuo, N.Y. Shih, and L.K. Siu Development of high-level carbapenem resistance in Klebsiella pneumoniae among patients with prolonged hospitalization and carbapenem exposure Microb Drug Resist 16 2010 317 325